Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
批准号:
10541156
负责人:
Namasivayam Ambalavanan
金额:
$152.13万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-12-15 至 2026-11-30
关键词:
AccelerationAgeAge MonthsAsthmaBreathingBronchopulmonary DysplasiaCaffeineCharacteristicsChildChild CareChildhoodClinicalClinical DataClinical TreatmentCognitiveCollaborationsConsentDataDevelopmentDiagnosisDiscipline of NursingDiseaseEarly DiagnosisEarly InterventionEarly identificationEmotionalEnrollmentEventFrequenciesFundingFutureGoalsHealthHypoxemiaImpairmentInfantInfrastructureInstitutionInterventionIntervention TrialInvestigationKnowledgeLifeLinkMeasuresMotorNational Heart, Lung, and Blood InstituteNeonatalNeonatal Intensive CareNeonatal Intensive Care UnitsNervous System PhysiologyNeurodevelopmental ImpairmentNursery SchoolsOutcomeOxygenPathologicPathway interactionsPatientsPatternPersonsPharmaceutical PreparationsPhysiologicalPopulationPregnancyPremature BirthPremature InfantPrevalencePrevention strategyPreventivePrognosisProspective StudiesProtocols documentationRecordsRehabilitation therapyResearchResearch PersonnelResolutionResourcesRespiratory physiologyRiskRodentRoleSchool-Age PopulationSensoryServicesSleepSleep Apnea SyndromesStructureSystemTherapeuticTimeTrainingUnited States National Institutes of HealthVentWeaningWorkadvanced analyticsairway hyperresponsivenessasthma modelclinical careclinical phenotypecohortcostearly screeningempowermentexperienceextreme prematurityimprovedinfancyinnovationnegative affectneonatal carenovel therapeuticspeerpostnatalprematureprognosticprognostic modelprogramsrespiratoryresponsestandard of caresupplemental oxygentargeted treatment
中文摘要
项目摘要/摘要
这是早产相关呼吸控制(PREVENT)合作者的应用:
呼吸结果NHLBI合作计划。这项建议的核心是一项前瞻性研究,题为
《后遗症:新生儿间歇性后果的个性化预测模型》
学龄前早产儿的低氧血症“。该多中心方案创新性地结合了详细的
间歇性低氧血症(IH)事件纵向记录的临床表型和高级分析
开发个性化的长期结果预测模型,通过允许
及时识别高危婴儿和特定的病理IH模式,为将来的靶向干预试验做准备。
极早产和各种出生后因素会对结局产生负面影响。在相当大的比例中
极早产儿的后遗症持续到婴儿期以后,哮喘和睡眠的发生率相对较高。
儿童时期的呼吸紊乱(SDB)和令人担忧的神经发育障碍(NDI)的流行。
这一多中心方案将系统地和创新性地研究新生儿期间IH之间的相互作用
重症监护和这些后遗症通过详细的临床表型和先进的分析手段。这个
拟议的调查将提供个性化的预后和对长期处于不良风险的婴儿的识别
可能改变临床护理并发现预防或治疗策略的目标的结果。
这项建议的主要目标是建立哮喘、SDB和NDI在学龄前儿童中的预后模型
极早产儿的生理波形与新生儿临床特征
重症监护室。为了实现这一目标,这项时间敏感的提案利用了人口、研究结构
和专业知识,以及为NHLBI资助的事件前合作开发的分析资源。
英文摘要
Project Summary / Abstract
This is the application from collaborators of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in
Respiratory Outcomes NHLBI Collaborative Program. Central to this proposal is a prospective study entitled
“Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent
Hypoxemia in Preterm Infants at Pre-school Age”. This multicenter proposal innovatively combines detailed
clinical phenotyping with advanced analytics of longitudinal recordings of intermittent hypoxemia (IH) events to
develop personalized prognostic models of long-term outcomes that could transform clinical care by allowing for
timely identification of at-risk infants and specific pathologic IH patterns for future trials of targeted intervention.
Extremely premature birth and various postnatal factors can negatively affect outcome. In a significant proportion
of extremely premature infants the sequelae persist beyond infancy with relatively high rates of asthma and sleep
disordered breathing (SDB) in childhood and worrisome prevalence of neurodevelopmental impairment (NDI).
This multicenter proposal will systematically and innovatively examine the interaction between IH during neonatal
intensive care and these sequelae by means of detailed clinical phenotyping and advanced analytics. The
proposed investigation will provide personalized prognosis and identification of infants at risk of poor long-term
outcome that could transform clinical care and uncover targets for preventive or therapeutic strategies.
The main goal of this proposal is to build prognostic models of asthma, SDB, and NDI at pre-school age in former
extremely premature infants based on physiologic waveforms and clinical characteristics in the neonatal
intensive care unit. To achieve this goal this time-sensitive proposal leverages the population, research structure
and expertise, and analytic resources developed for the NHLBI-funded Pre-Vent collaboration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Let-7b in BPD
-
批准号:10655734
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2023
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
-
批准号:10576754
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2023
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Vital Signs In Opioid-Exposed Neonates
-
批准号:10493363
-
项目类别:
-
资助金额:$50.77万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
-
批准号:10891299
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
-
批准号:10363406
-
项目类别:
-
资助金额:$148.56万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
-
批准号:10372486
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Vital Signs In Opioid-Exposed Neonates
-
批准号:10360908
-
项目类别:
-
资助金额:$51.99万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Acute Renal Injury Sequelae in NICU Graduates (ARISING)
-
批准号:9899244
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2019
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:10006023
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:9762173
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:9168075
-
项目类别:
-
资助金额:$19.53万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:9292368
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:9143795
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:8996355
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:9062496
-
项目类别:
-
资助金额:$73.48万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:8685690
-
项目类别:
-
资助金额:$74.01万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:8870421
-
项目类别:
-
资助金额:$73.5万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8240026
-
项目类别:
-
资助金额:$59.75万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8610334
-
项目类别:
-
资助金额:$57.19万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8015539
-
项目类别:
-
资助金额:$62.29万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: